COA / COA-2026-0200
Selank / Semax 5/5 mg
Lot COA-2026-0200
99.80% (3-vial average)HPLC
Report date
2026-09-03
Testing lab
AV Analytics
Appearance
Lyophilized
| Analyte | Method | Result |
|---|---|---|
| Purity | UPLC-UV + UPLC-MS | 99.80% (3-vial average) |
| Identity | UPLC-UV + UPLC-MS | Conforms (UPLC-MS ionization profile match) |
| Net peptide content | UPLC-UV + UPLC-MS | Vial 1 5.11 / 5.06 mg (vials 2–3 received breached, not reported) |
| Endotoxin | LAL, USP <85> | Pass (rFC, <0.5 EU/mL; vials 0.11) |
Independent analysis by AV Analytics. Results apply to the stated lot. For laboratory and research use only — not for human or animal consumption.